First in human study of NVI 100
Latest Information Update: 15 Jan 2025
Price :
$35 *
At a glance
- Drugs NVI 100 (Primary)
- Indications Migraine
- Focus Adverse reactions; First in man; Pharmacokinetics
- 15 Jan 2025 New trial record
- 08 Jan 2025 Results presented in the Nuvie Bio Media Release.